BioSpace News Archive

Genetown

Not Just Road Rage: Understanding Intermittent Explosive Disorder, from the Harvard Mental Health Letter

April 7, 2011
·
1 min read
BioForest

Tekmira Pharmaceuticals Corporation Comments on Answer and Counterclaim Filed by Alnylam Pharmaceuticals

April 7, 2011
·
1 min read
Drug Development

Teva Pharmaceutical Industries Limited and OncoGenex Pharmaceuticals Inc. Present Preclinical Data on the Activity of its Antisense Compound Custirsen (OGX-011/TV-1011) at the American Association for Cancer Research Annual Meeting 2011

April 7, 2011
·
8 min read
Drug Development

BioTie Therapies Corp. Announces Start of Phase 2b Trial of SYN115 in Parkinson’s Disease

April 7, 2011
·
3 min read
Policy

Allergy Therapeutics plc Submits Grass MATA MPL Dossier in Switzerland

April 7, 2011
·
3 min read
Drug Development

NanoViricides, Inc. Reports FluCide(TM) Drug Candidates Found to Offer Significant Reduction in Damaging White Blood Cell Presence in Lung Tissue in Lethal Influenza Infection Animal Study

April 7, 2011
·
1 min read
Deals

Jilin Aodong Makes $2 Million Initial Investment in Vital Therapies, Inc. (VTI)

April 7, 2011
·
1 min read
Drug Development

Lpath, Inc. Initiates Enrollment of iSONEP Phase 1b/2a Proof-of-Concept Trial

April 7, 2011
·
5 min read
Drug Development

CEL-SCI Receives Government Approval in India to Commence Phase III Clinical Trial of Multikine in Head and Neck Cancer

April 7, 2011
·
1 min read
Drug Development

Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) Initiates Dosing in the Phase 1b/2a START-FAP Clinical Trial of CEQ508

April 7, 2011
·
5 min read